rechARge: a randomized phase III trial of the androgen receptor ligand-directed degrader, BMS-986365, vs investigator’s choice in patients with mCRPC
Kim Nguyen, Rana R. McKay, Shahneen Sandhu, José Ángel Arranz, Philippe Barthélémy, Boris Hadaschik, Nobuaki Matsubara, Neal D. Shore, Dingwei Ye, Teresa Cascella, Irina Irincheeva, Stephanie Kreiser, Antoine Thiery-Vuillemin, Dana E. Rathkopf (2025). rechARge: a randomized phase III trial of the androgen receptor ligand-directed degrader, BMS-986365, vs investigator’s choice in patients with mCRPC. , 21(14), DOI: https://doi.org/10.1080/14796694.2025.2502318.
